SlideShare ist ein Scribd-Unternehmen logo
1 von 41
Overview of ICH E9:  Statistical Principles for Clinical Trials         Presented by Jeff Davidson
ICH E9 cover page ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Scope and Direction
[object Object],[object Object],[object Object],[object Object],Unjustified statistics are like smiling cats - not to be trusted.  Scope and Direction
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Scope and Direction
[object Object],[object Object],[object Object],Scope and Direction
[object Object],[object Object],[object Object],Protocol and Analysis Plan
Types of Trials ,[object Object],Confirmatory Trial
Exploratory Trial ,[object Object],[object Object]
Confirmatory Trial ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Population ,[object Object],[object Object],[object Object],[object Object]
Outcome Variables ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Avoiding Bias by Design: Blinding ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Avoiding Bias by Design: Randomization ,[object Object],[object Object],[object Object]
[object Object],[object Object],Design Configuration Population A B
[object Object],[object Object],[object Object],[object Object],Design Configuration Population A B B A
[object Object],Design Configuration Population A (A1, A2) B (B1,B2) A1, B1 A1, B2 A2, B1 A2, B2
Other Study Designs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Type of Comparison ,[object Object],[object Object],[object Object],[object Object],[object Object]
Type of Comparison ,[object Object],[object Object],[object Object],[object Object],[object Object]
Type of Comparison ,[object Object],[object Object],[object Object],[object Object]
 
Type of comparison ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Sample Size ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Data Monitoring ,[object Object],[object Object]
Oversight of Trial Quality ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Monitoring Treatment Effects: Interim Analysis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Monitoring Treatment Effects: Interim Analysis  ,[object Object],Independent  Statistical Team Study Team IRB Sponsor DMC
Monitoring Treatment Effects: Interim Analysis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Data Analysis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Analysis Sets ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Full Analysis Set ,[object Object],[object Object],[object Object]
Full Analysis Set ,[object Object],[object Object],[object Object],[object Object],[object Object]
Per Protocol Set ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Estimation and Confidence Intervals ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Evaluation of Safety ,[object Object],[object Object],[object Object]
Example of an  unacceptable  adverse event
Evaluation of Safety is  critical to the success  of a new drug
Reporting ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object]

Weitere ähnliche Inhalte

Was ist angesagt?

Biostatistics in Clinical Research
Biostatistics in Clinical ResearchBiostatistics in Clinical Research
Biostatistics in Clinical ResearchAbhaya Indrayan
 
Understanding clinical trial's statistics
Understanding clinical trial's statisticsUnderstanding clinical trial's statistics
Understanding clinical trial's statisticsMagdy Khames Aly
 
Clinical trials its types and designs
Clinical trials  its types and designsClinical trials  its types and designs
Clinical trials its types and designsDevesh Aggarwal
 
Statistical analysis of clinical data isi 30 01 07
Statistical analysis of clinical data isi 30 01 07Statistical analysis of clinical data isi 30 01 07
Statistical analysis of clinical data isi 30 01 07Bhaswat Chakraborty
 
Adaptive Study Designs
Adaptive Study DesignsAdaptive Study Designs
Adaptive Study DesignsAnirudha Potey
 
Case report form and application
Case report  form  and  applicationCase report  form  and  application
Case report form and applicationIrene Vadakkan
 
Medical research and study design
Medical research and study designMedical research and study design
Medical research and study designNaveen Phuyal
 
Clinical Research Statistics for Non-Statisticians
Clinical Research Statistics for Non-StatisticiansClinical Research Statistics for Non-Statisticians
Clinical Research Statistics for Non-StatisticiansBrook White, PMP
 
Case Report Form (CRF) Design Tips
Case Report Form (CRF) Design TipsCase Report Form (CRF) Design Tips
Case Report Form (CRF) Design TipsPerficient
 
Adaptive Clinical Trials
Adaptive Clinical TrialsAdaptive Clinical Trials
Adaptive Clinical TrialsJay1818mar
 
Introduction to clinical trials
Introduction to clinical trialsIntroduction to clinical trials
Introduction to clinical trialsShriyaDeshpande5
 
Adaptive Design
Adaptive DesignAdaptive Design
Adaptive Designcasiopeita
 
Patient recruitment
Patient recruitmentPatient recruitment
Patient recruitmentswati2084
 
Research Methodology General.ppt
Research  Methodology  General.pptResearch  Methodology  General.ppt
Research Methodology General.pptShama
 
Clinical trial design
Clinical trial designClinical trial design
Clinical trial designUrmila Aswar
 
Crossover design ppt
Crossover design pptCrossover design ppt
Crossover design pptHARISH J
 

Was ist angesagt? (20)

Biostatistics in Clinical Research
Biostatistics in Clinical ResearchBiostatistics in Clinical Research
Biostatistics in Clinical Research
 
Clinical trial design
Clinical trial designClinical trial design
Clinical trial design
 
Understanding clinical trial's statistics
Understanding clinical trial's statisticsUnderstanding clinical trial's statistics
Understanding clinical trial's statistics
 
Clinical trials its types and designs
Clinical trials  its types and designsClinical trials  its types and designs
Clinical trials its types and designs
 
Statistical analysis of clinical data isi 30 01 07
Statistical analysis of clinical data isi 30 01 07Statistical analysis of clinical data isi 30 01 07
Statistical analysis of clinical data isi 30 01 07
 
Adaptive Study Designs
Adaptive Study DesignsAdaptive Study Designs
Adaptive Study Designs
 
Crossover study design
Crossover study designCrossover study design
Crossover study design
 
Case report form and application
Case report  form  and  applicationCase report  form  and  application
Case report form and application
 
Medical research and study design
Medical research and study designMedical research and study design
Medical research and study design
 
Clinical Research Statistics for Non-Statisticians
Clinical Research Statistics for Non-StatisticiansClinical Research Statistics for Non-Statisticians
Clinical Research Statistics for Non-Statisticians
 
Case Report Form (CRF) Design Tips
Case Report Form (CRF) Design TipsCase Report Form (CRF) Design Tips
Case Report Form (CRF) Design Tips
 
Ctri
CtriCtri
Ctri
 
Adaptive Clinical Trials
Adaptive Clinical TrialsAdaptive Clinical Trials
Adaptive Clinical Trials
 
Introduction to clinical trials
Introduction to clinical trialsIntroduction to clinical trials
Introduction to clinical trials
 
Adaptive Design
Adaptive DesignAdaptive Design
Adaptive Design
 
Data management & statistics in clinical trials
Data management & statistics in clinical trialsData management & statistics in clinical trials
Data management & statistics in clinical trials
 
Patient recruitment
Patient recruitmentPatient recruitment
Patient recruitment
 
Research Methodology General.ppt
Research  Methodology  General.pptResearch  Methodology  General.ppt
Research Methodology General.ppt
 
Clinical trial design
Clinical trial designClinical trial design
Clinical trial design
 
Crossover design ppt
Crossover design pptCrossover design ppt
Crossover design ppt
 

Andere mochten auch

ICH E9 (Statistical Principles for Clinical Trials E9)
ICH E9 (Statistical Principles for Clinical Trials E9)ICH E9 (Statistical Principles for Clinical Trials E9)
ICH E9 (Statistical Principles for Clinical Trials E9)PHARMADVISOR
 
Ich Fda Socra 09 2007
Ich Fda Socra 09 2007Ich Fda Socra 09 2007
Ich Fda Socra 09 2007jsf5328
 
Surrogate endpoints: a regulatory review
Surrogate endpoints: a regulatory reviewSurrogate endpoints: a regulatory review
Surrogate endpoints: a regulatory reviewTim Felgate
 
FDA 2013 Clinical Investigator Training Course: Clinical Trial Endpoints
FDA 2013 Clinical Investigator Training Course: Clinical Trial EndpointsFDA 2013 Clinical Investigator Training Course: Clinical Trial Endpoints
FDA 2013 Clinical Investigator Training Course: Clinical Trial EndpointsMedicReS
 
Ethical guidelines of clinical trials.
Ethical guidelines of clinical trials.Ethical guidelines of clinical trials.
Ethical guidelines of clinical trials.Ashu Koli
 
History ethical guide lines to clinical trial
History ethical guide lines to clinical trialHistory ethical guide lines to clinical trial
History ethical guide lines to clinical trialAnju Thejkumar
 
Clinical practice guidelines
Clinical practice guidelinesClinical practice guidelines
Clinical practice guidelinesabenedicto
 
Parkinsonism.ppt
Parkinsonism.pptParkinsonism.ppt
Parkinsonism.pptShama
 
Drug distribution & drug elimination pharmacology
Drug distribution & drug elimination pharmacologyDrug distribution & drug elimination pharmacology
Drug distribution & drug elimination pharmacologyVishnu Priya
 
Parkinson’S Disease
Parkinson’S DiseaseParkinson’S Disease
Parkinson’S Diseaseguest27ee33
 
ICH Guideline Q9 - Quality Risk Management
ICH Guideline Q9 - Quality Risk ManagementICH Guideline Q9 - Quality Risk Management
ICH Guideline Q9 - Quality Risk Managementmuna_ali
 
Clinical Pathways
Clinical PathwaysClinical Pathways
Clinical Pathwayspradhasrini
 

Andere mochten auch (17)

ICH E9 (Statistical Principles for Clinical Trials E9)
ICH E9 (Statistical Principles for Clinical Trials E9)ICH E9 (Statistical Principles for Clinical Trials E9)
ICH E9 (Statistical Principles for Clinical Trials E9)
 
Ich Fda Socra 09 2007
Ich Fda Socra 09 2007Ich Fda Socra 09 2007
Ich Fda Socra 09 2007
 
Surrogate endpoints: a regulatory review
Surrogate endpoints: a regulatory reviewSurrogate endpoints: a regulatory review
Surrogate endpoints: a regulatory review
 
FDA 2013 Clinical Investigator Training Course: Clinical Trial Endpoints
FDA 2013 Clinical Investigator Training Course: Clinical Trial EndpointsFDA 2013 Clinical Investigator Training Course: Clinical Trial Endpoints
FDA 2013 Clinical Investigator Training Course: Clinical Trial Endpoints
 
Ethical guidelines of clinical trials.
Ethical guidelines of clinical trials.Ethical guidelines of clinical trials.
Ethical guidelines of clinical trials.
 
History ethical guide lines to clinical trial
History ethical guide lines to clinical trialHistory ethical guide lines to clinical trial
History ethical guide lines to clinical trial
 
Clinical practice guidelines
Clinical practice guidelinesClinical practice guidelines
Clinical practice guidelines
 
Parkinsonism.ppt
Parkinsonism.pptParkinsonism.ppt
Parkinsonism.ppt
 
Drug distribution & drug elimination pharmacology
Drug distribution & drug elimination pharmacologyDrug distribution & drug elimination pharmacology
Drug distribution & drug elimination pharmacology
 
ICH
ICHICH
ICH
 
Ich guidelines
Ich guidelinesIch guidelines
Ich guidelines
 
Parkinson’S Disease
Parkinson’S DiseaseParkinson’S Disease
Parkinson’S Disease
 
ICH GUIDELINES
ICH GUIDELINESICH GUIDELINES
ICH GUIDELINES
 
Clinical Trial Phases
Clinical Trial PhasesClinical Trial Phases
Clinical Trial Phases
 
ICH Guideline Q9 - Quality Risk Management
ICH Guideline Q9 - Quality Risk ManagementICH Guideline Q9 - Quality Risk Management
ICH Guideline Q9 - Quality Risk Management
 
Clinical Pathways
Clinical PathwaysClinical Pathways
Clinical Pathways
 
Clinical Trials - An Introduction
Clinical Trials - An IntroductionClinical Trials - An Introduction
Clinical Trials - An Introduction
 

Ähnlich wie Overview Of Ich New E9

9-Meta Analysis/ Systematic Review
9-Meta Analysis/ Systematic Review9-Meta Analysis/ Systematic Review
9-Meta Analysis/ Systematic ReviewResearchGuru
 
RCT to causal inference.pptx
RCT to causal inference.pptxRCT to causal inference.pptx
RCT to causal inference.pptxFrancois MAIGNEN
 
When to Select Observational Studies as Evidence for Comparative Effectivenes...
When to Select Observational Studies as Evidence for Comparative Effectivenes...When to Select Observational Studies as Evidence for Comparative Effectivenes...
When to Select Observational Studies as Evidence for Comparative Effectivenes...Effective Health Care Program
 
EBM Therapy Appraisal Template F1
EBM Therapy Appraisal Template F1EBM Therapy Appraisal Template F1
EBM Therapy Appraisal Template F1Imad Hassan
 
Clinical trial design, Trial Size, and Study Population
Clinical trial design, Trial Size, and Study Population Clinical trial design, Trial Size, and Study Population
Clinical trial design, Trial Size, and Study Population Shubham Chinchulkar
 
NES Pharmacy, Critical Appraisal 2011
NES Pharmacy, Critical Appraisal 2011NES Pharmacy, Critical Appraisal 2011
NES Pharmacy, Critical Appraisal 2011NES
 
# 9th lect clinical trial analysis
# 9th lect  clinical  trial analysis# 9th lect  clinical  trial analysis
# 9th lect clinical trial analysisDr. Eman M. Mortada
 
JC SEBMA Prognosis Appraisal Template V1
JC SEBMA Prognosis Appraisal Template V1JC SEBMA Prognosis Appraisal Template V1
JC SEBMA Prognosis Appraisal Template V1Imad Hassan
 
research design
research designresearch design
research designRajeshwori
 
Research Methodology - Dr Kusum Gaur
Research Methodology - Dr Kusum GaurResearch Methodology - Dr Kusum Gaur
Research Methodology - Dr Kusum Gaurmrinal joshi
 
biostatists presentation
biostatists presentationbiostatists presentation
biostatists presentationAnil kumar
 
HLinc presentation: levels of evidence
HLinc presentation:  levels of evidenceHLinc presentation:  levels of evidence
HLinc presentation: levels of evidenceCatherineVoutier
 
Doc 20181126-wa0018
Doc 20181126-wa0018Doc 20181126-wa0018
Doc 20181126-wa0018siwaniteki
 
Systematic Reviews Class 4c
Systematic Reviews Class 4cSystematic Reviews Class 4c
Systematic Reviews Class 4cguestf5d7ac
 
Eblm pres final
Eblm pres finalEblm pres final
Eblm pres finalprasath172
 

Ähnlich wie Overview Of Ich New E9 (20)

Clinical trials
Clinical trials Clinical trials
Clinical trials
 
9-Meta Analysis/ Systematic Review
9-Meta Analysis/ Systematic Review9-Meta Analysis/ Systematic Review
9-Meta Analysis/ Systematic Review
 
RCT to causal inference.pptx
RCT to causal inference.pptxRCT to causal inference.pptx
RCT to causal inference.pptx
 
When to Select Observational Studies as Evidence for Comparative Effectivenes...
When to Select Observational Studies as Evidence for Comparative Effectivenes...When to Select Observational Studies as Evidence for Comparative Effectivenes...
When to Select Observational Studies as Evidence for Comparative Effectivenes...
 
Study Eligibility Criteria
Study Eligibility CriteriaStudy Eligibility Criteria
Study Eligibility Criteria
 
EBM Therapy Appraisal Template F1
EBM Therapy Appraisal Template F1EBM Therapy Appraisal Template F1
EBM Therapy Appraisal Template F1
 
Clinical trial design, Trial Size, and Study Population
Clinical trial design, Trial Size, and Study Population Clinical trial design, Trial Size, and Study Population
Clinical trial design, Trial Size, and Study Population
 
NES Pharmacy, Critical Appraisal 2011
NES Pharmacy, Critical Appraisal 2011NES Pharmacy, Critical Appraisal 2011
NES Pharmacy, Critical Appraisal 2011
 
Ebd jc part 5
Ebd jc part 5Ebd jc part 5
Ebd jc part 5
 
# 9th lect clinical trial analysis
# 9th lect  clinical  trial analysis# 9th lect  clinical  trial analysis
# 9th lect clinical trial analysis
 
Randomized controlled trials
Randomized controlled trialsRandomized controlled trials
Randomized controlled trials
 
JC SEBMA Prognosis Appraisal Template V1
JC SEBMA Prognosis Appraisal Template V1JC SEBMA Prognosis Appraisal Template V1
JC SEBMA Prognosis Appraisal Template V1
 
research design
research designresearch design
research design
 
Research Methodology - Dr Kusum Gaur
Research Methodology - Dr Kusum GaurResearch Methodology - Dr Kusum Gaur
Research Methodology - Dr Kusum Gaur
 
biostatists presentation
biostatists presentationbiostatists presentation
biostatists presentation
 
HLinc presentation: levels of evidence
HLinc presentation:  levels of evidenceHLinc presentation:  levels of evidence
HLinc presentation: levels of evidence
 
Doc 20181126-wa0018
Doc 20181126-wa0018Doc 20181126-wa0018
Doc 20181126-wa0018
 
Metaanalysis copy
Metaanalysis    copyMetaanalysis    copy
Metaanalysis copy
 
Systematic Reviews Class 4c
Systematic Reviews Class 4cSystematic Reviews Class 4c
Systematic Reviews Class 4c
 
Eblm pres final
Eblm pres finalEblm pres final
Eblm pres final
 

Overview Of Ich New E9

  • 1. Overview of ICH E9: Statistical Principles for Clinical Trials Presented by Jeff Davidson
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 23.  
  • 24.
  • 25.
  • 26.
  • 27.
  • 28.
  • 29.
  • 30.
  • 31.
  • 32.
  • 33.
  • 34.
  • 35.
  • 36.
  • 37.
  • 38. Example of an unacceptable adverse event
  • 39. Evaluation of Safety is critical to the success of a new drug
  • 40.
  • 41.